Description
Since its foundation in 2001, Biotechnet has executed over 150 successful projects with industry and other research partners. Here are a few highlights from 2019-2021.
Swiss Biotech Report 2022: Working together towards innovation that matters
- Automated engineering and analysis of 3D-human skeletal muscle models for the investigation of potential treatments of muscle wasting diseases (ZHAW, Novartis, Innosuisse)
- in vitro models to evaluate the interaction of Perseo’s nanomedicine with biological barriers (Perseo pharma, FHNW)
- 3D-liver models for therapeutic antibody against liver fibrosis (Alentis Therapeutics, FHNW)
- AI technology to label therapeutic antibodies with an imaging load (HES-SO Valais, CHUV, Debiopharm, Innosuisse)
- Optical Blood Pressure Monitoring (OBPM) technology for hypertension (Aktiia, CSEM)
- Platform to deliver personalized ovarian cancer therapy (AnaPath Services GmbH, FHNW, Eurostars)
- World’s first automated machine to produce customized skin tissue grafts (CUTISS, CSEM)
- Device to test the efficacy of antiparasitic drugs (INVENesis, INRAE, CSEM)
- Advanced organoid technology to model host-parasite interactions (SUN bioscience, EPFL, CSEM, FHNW)
- 3D-printed, tailor-made bioreactors for pharma and medicine: Flexibility by additive manufacturing (ZHAW, Presens, Applikon, Levitronix, Neue Materialien Bayreuth, EUROSTAR)
Swiss Biotech Report 2021: Public-private partnerships generate prompt response to COVID-19
- Human microphysiological systems (MPS) to better understand SARS-CoV-2 (ZHAW, FHNW)
- POC diagnostics for tracing SARS-CoV-2 (CSEM, HES-SO)
- Detecting COVID-19 in saliva: home‐use rapid diagnostic tests (DAVINCI consortium, CSEM, Botnar Research Centre)
- Mass testing: PCR-based COVID-19 tests in saliva for a large number of students (FHNW, Biolytix AG, Kanton Baselland)
- Virablock: Intelligent textiles for masks (HeiQ Materials AG, FHNW)
- COMO Real-time remote patient monitoring (Vexatec, CSEM, EOS S.R.L)
- Optical sensors to test for previous infection (Adamant Innotech, CSEM)
- Talent development: Digitalization, automation and control of biotechnology processes (Lonza, HES-SO, Ibex Biopark)
- Process development for COVID 19 VLP vaccine production (ZHAW, Saiba, University Bern)
Swiss Biotech Report 2020: Strategic interactions for dynamic times
- 0.3mm diameter spherical cell culture model for formation of liver fibrosis (FHNW, InSphero AG, Innosuisse)
- Summer School on Advanced Biotechnology (University of Palermo, FHNW)
- Summer School on Health and the Environment (FHNW, Nanjing University, China and the International Institute for Environmental Studies, Canada)
